**Kymera Therapeutics, Inc. 2025 Q3 Results Earnings Call Presentation**
*Date: November 4, 2025 | Time: 6:16 PM ET*
Kymera Therapeutics, Inc. (NYSE: KYMR) recently released their earnings results for the third quarter of 2025. Below is a summary of their financial performance and related details from the earnings call.
**Q3 2025 Earnings Summary:**
– Earnings Per Share (EPS): -$0.94, missing estimates by $0.16
– Revenue: $2.76 million, down 26.12% year-over-year, missing estimates by $20.79 million
The company also published a slide deck to accompany the Q3 earnings call. This presentation provides further insights into Kymera Therapeutics’ performance and outlook.
—
This article was prepared using the transcript provided by Seeking Alpha’s transcripts team, who are responsible for developing and maintaining comprehensive quarterly earnings call coverage. Seeking Alpha currently publishes thousands of quarterly earnings transcripts each quarter and continues to expand its content and features.
We aim to keep our readers informed about new transcript-related developments and detailed financial updates from companies like Kymera Therapeutics.
*Thank you,*
**The Seeking Alpha Transcripts Team**
—
**Recommended For You:**
[Related articles and transcripts to explore]
https://seekingalpha.com/article/4837834-kymera-therapeutics-inc-2025-q3-results-earnings-call-presentation?source=feed_all_articles